GlassScriptPhysician profile
Kenneth J Helal
NPI 1548248214
$1,864.67
in general payments reported to CMS, 2019-2025
20 companies · $538 in 2025
The $538 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $104 · 2021: $75.11 · 2022: $128 · 2023: $281 · 2024: $465 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $429.05 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $266.74 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $234.86 | 2019-2022 | |
| Hologic Sales and Service, LLC | $206.84 | 2020-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $144.37 | 2019-2025 | |
| Exeltis, USA INC. | $82.05 | 2022-2025 | Slynd |
| Organon LLC | $66.62 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $62.02 | 2020-2024 | Paragard T 380a |
| Exact Sciences Corporation | $57.24 | 2023-2024 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $52.52 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $52.45 | 2024 | Perclot |
| Coloplast Corp | $38.96 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $28.31 | 2019 | |
| Mayne Pharma Commercial LLC | $28.23 | 2025 | |
| Avanos Medical | $26.98 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $21.66 | 2025 | Fibryga |
| Pfizer INC. | $18.56 | 2025 | |
| Sanofi Pasteur INC. | $16.95 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.88 | 2019 | |
| Myovant Sciences INC. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Helal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.